1 Friedrichsen GM, Nielsen CU, Steffansen B, BegtrupM.Model prodrug designed for the intestinal peptide transporter.A Synthetic approach for coupling of hydroxy containing compounds to dipeptides[J].Eur J Pharm Sci , 2001;14:13-9
2 Ichi K, Masuda S, Satio H.Cellular and molecular aspects of drug transport in the kidney[J].Kidney Int, 2000;58:944-58
3 Shimakura J, Terada T, Katsura T, Inui K.Characterization of the human peptide transporter PEPT1 promoter:Sp1 functions as a basal transcriptional regulator of human PEPT1[J].Am J Physiol, 2005;289:471-7
4 Gaildrat P, Moller M, Mukda S, Humphries A, Carter DA,Ganapathy V, et al.A novel pineal-specific product of the oligopeptide transporter PepT1 gene:circadian expression mediated by cAMpactivation of an intronic promoter[J].J Biol Chem , 2005;280:16851-60
5 Vavricka SR, Musch MW, Fujiy a M, Kles K, Chang L, Eloranta JJ, et al.Tumor necrosis factor-alpha and interferon-gamma increase PepT1 expression and activity in the human colon carcinoma cell line Caco-2/ bbe and in mouse intestine[J].Pflugers Arch, 2006;452:71-80
6 Pan X, Terada T, Okuda M, Inui K.Altered diurnal rhythm of intestinal peptide transporter by fasting and its effects on the pharmacokinetics of ceftibuten[J].J Pharmacol ExpTher ,2003;307:626-32
7 Friedrichsen GM, Jakobsen P, Taub M, BegtrupM.Application of enzymatically stable dipeptides for enhancement of intestinal permeability.Synthesis and in vitro evaluation of dipeptidecoupled compounds[J].Bioorg Med Chem, 2001;9:2625-32
8 Anand BS, Patel J, Mitra AK.Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter:competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2[J].J Pharmacol ExpTher ,2003;304:781-91
9 Lepist EI, Kusk T, Larsen DH, Andersen D, Frokjaer S, Taub ME, et al.Stability and in vitro metabolism of dipeptide model prodrugs with affinity for the oligopeptide transporter[J].Eur J Pharm Sci, 2000;11:43-50
10 De Vrueh RL, Smith PL, Lee CP.Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line , Caco-2[J].J Pharmacol ExpTher , 1998;286:1166-70
11 Lin JH, Yamazaki M.Role of P-glycoprotein in pharmacokinetics:clinical implications[J].Clin Pharmacokinet JT, 2003;42:59-98
12 Lamipids TJ, Kolonias D, Podona T.Circumvention of p-gpMDR as a function of anthraxcycline lipophilicity and charge[J].J Bioche mistry , 1997;36:2769-75
13 Veau C, Leroye, Banide H, Auchere D, Tardivel S, Farinotti R, et al.Effect of chronic renal failure on the expression and function of rat intestinal p-gly coprotein in drug excretion[J].Nephrol Dial Transplant , 2001;16:1607-14
14 Toshiya K, Ken-ichi I.Intestinal absorption of drugs mediated by drug transporter:mechanisms and regulation[J].Drug Metab.Pharmacokin , 2003;18:1-15
15 Taipalensuu J, Tomblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, et al.Correlation of gene expression of ten drug efflux protein of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers[J].J Pharmacol ExpTher, 2001;299:167-70
16 Hiroshi M, Toshiya K, Kayoko A, Yukiya H, Ken-Ichi I.Diphenhydramine transport by pH-dependent tertiary amine transport system in Caco-2 cells[J].Am J Physiol Gastrointest Liver Physiol , 2000;278:G563-9
17 Toshiya K, Hiroshi M, Yukiya H, Ken-Ichi I.Transport of procainamide via H +/tertiary amine antiport system in rabbit intestinal brush-border membrane[J].Am J Physiol Gastrointest Liver Physiol , 2000;279:G799-805
18 Ikumi T, Ayaka Si, Ryoichi S, Yoshimichi S, Ichimaro Y,Akira T.Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters[J].J Pharmacol ExpTher , 1997;283:108-15
19 Atsuko F, Hideyuki S, Ken-ichi I.Transport mechanisms of nicotine across the human intestinal epithelial cell line Caco-2[J].J Pharmacol ExpTher , 2002;302:532-8
20 Li YH, Kiyomi I, Yasuyuki T, Rikako K, Hideo Y, Tomoo I.Mechanism of intestinal absorption of an orally active β-lactam prodrug:uptake and transport of carindacillin in Caco-2 cells[J].J Pharmacol ExpTher , 1999;290:958-64
21 Okamura A, Emoto A, Koyabu N, Ohtani H, Sawada Y.Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1[J] Br [J] Pharmacol , 2002;137:391-9
22 Kirchheiner J, Henckel HB, Meineke I, Roots I, Brockmoller J.Impact of the CYP2D6 ultrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteers[J].J Clin Psychopharmacol, 2004;24:647-52
23 Guay DR.Clinical pharmacokinetics of drugs used to treat urge incontinence[J].Clin Pharmacokinet JT, 2003;42:1243 -85 Chin J Clin Pharmacol Ther2006 Sep;11(9)
24 Maffia M, Acierno R, Cillo E, Storelli C.Na(+)-D-glucose cotransport by intestinal BBMVs of the Antarctic fish Trematomus bernacchii[J].Am J Physiol Regul Integr CompPhysiol , 1996;271:1576-83
25 Sun Y, J Chen JD.Intestinal electric stimulation decreases fat absorption in rats:therapeutic potential for obesity[J].Obesity Research, 2004;12:1235-42
26 Mineo H, Amano M, Chiji H, Shigematsu N, Tomita F, Hara H.Indigestible disaccharides open tight junctions and enhance net calcium, magnesium , and zinc absorption in isolated rat small and large intestinal epithelium[J].Dig Dis Sci, 2004;49:122-32
27 Kottra G, Stamfort A, Daniel H.PEPT1 as a paradigm for membrane carriers that mediate electrogenic bidirectional transport of anionic , cationic , and neutral substrates[J].J Biol Chem, 2002;277:32683-91
28 Mackenzie B, Loo DD, Fei Y, Liu WJ, Ganapathy V, Leibach FH, et al.Mechanisms of the human intestinal H+-coupled oligopeptide transporter hPEPT1[J].J Pharmacol ExpTher ,1996;271:5430-7 |
